MAI Capital Management

Position in CRDF — Cardiff Oncology, Inc.

CIK 1040197 INDEPENDENCE, OH

Position in CRDF

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$30,384

-$17,412 QoQ

Shares Held

23,373

-20.8% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#49

of 104 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

MAI Capital Management holds $23,626,176 across 53 Biotechnology names. CRDF ranks #47 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	6,715	$4,187,071
2	VRTX	Vertex Pharmaceuticals Inc / Ma	5,638	$2,800,563
3	DNLI	Denali Therapeutics Inc.	49,160	$1,264,394
4	INCY	Incyte Corp	10,126	$1,147,882
5	TRVI	Trevi Therapeutics, Inc.	56,130	$1,046,824
6	RVMD	Revolution Medicines, Inc.	5,147	$963,929
7	LGND	Ligand Pharmaceuticals Inc	2,963	$936,574
8	EXEL	Exelixis, Inc.	13,982	$760,760

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$30,384	23,373	-20.8%	Shares	Defined	2026-08-14
2026-03-31	$47,796	29,504	-42.8%	Shares	Sole	2026-05-15
2025-12-31	$144,970	51,591	-22.2%	Shares	Sole	2026-02-13
2025-09-30	$136,561	66,292	-86.9%	Shares	Sole	2025-11-10
2025-06-30	$1,591,370	505,197	-46.2%	Shares	Sole	2025-08-12
2025-03-31	$2,950,322	939,593	+2.5%	Shares	Sole	2025-05-15
2024-12-31	$3,977,987	916,587	+38.2%	Shares	Sole	2025-02-14
2024-09-30	$1,771,179	663,363	+0.7%	Shares	Sole	2024-11-07
2024-06-30	$1,462,522	658,794	+19.5%	Shares	Sole	2024-08-12
2024-03-31	$2,943,002	551,124	+45.3%	Shares	Sole	2024-05-08
2023-12-31	$561,378	379,310	+68.8%	Shares	Sole	2024-02-09
2023-09-30	$312,401	224,749	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.